Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hadi Elias"'
Autor:
Ahmad Al-Abdouh, MD, Safi U. Khan, MD, Mahmoud Barbarawi, MD, Sireesha Upadhrasta, MD, Srajum Munira, MD, Anas Bizanti, MD, Hadi Elias, MD, Asadulla Jat, MD, Di Zhao, PhD, Erin D. Michos, MD, MHS
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 4, Pp 434-442 (2020)
Objective: To investigate the association between using febuxostat and cardiovascular events. Methods: Systematic search of randomized controlled trials was performed using PubMed/MEDLINE, Cochrane review, and EMBASE databases through April 17, 2019.
Externí odkaz:
https://doaj.org/article/b33d9210460349a0b1dbbc3c4304c447
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 5, Iss 1, Pp 6-14 (2019)
Immuno-oncology is a fast evolving field of cancer therapy and immune checkpoint inhibitors (ICIs) are clearly a breakthrough in this field. Cardiotoxicity with conventional anti-cancer therapies has been well studied in the past and clear guidelines
Externí odkaz:
https://doaj.org/article/b91444971101405b80c7c7722ba90885
Autor:
Osama Mahmoud, Hadi Mahmaljy, Mohamed Youniss, Edwin Hernandez Campoverde, Hadi Elias, Matthew Stanton, Maulin Patel, Insia Hashmi, Katelyn Young, Rajesh Kuppuraju, Steven Jacobs, Amro Alsaid
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 30, Iss , Pp 100586- (2020)
Background: The ideal high-sensitivity troponin (hsTn) cutoff for identifying those at low risk of 30 days events is debated; however, the 99th percentile overall or gender-specific upper reference limit (URL) is most commonly used. The magnitude of
Externí odkaz:
https://doaj.org/article/c4378e4fce92422486a285d9e3a16899
Autor:
Edwin Hernandez Campoverde, Matthew Stanton, Rajesh Kuppuraju, Maulin Patel, Insia Hashmi, Mohamed A. Youniss, Katelyn Young, Amro Alsaid, Hadi Mahmaljy, Hadi Elias, Osama Mahmoud, Steven Jacobs
Publikováno v:
Clinical Cardiology
Background The best disposition of chest pain patients who rule out for myocardial infarction (MI) but have non‐low clinical risk scores in the high‐sensitivity troponin era is not well studied. Hypothesis In carefully selected patients who rule
Autor:
Asadulla Jat, Ahmad Al-Abdouh, Erin D. Michos, Sireesha Upadhrasta, Anas Bizanti, Hadi Elias, Mahmoud Barbarawi, Srajum Munira, Safi U. Khan, Di Zhao
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 4, Pp 434-442 (2020)
Objective To investigate the association between using febuxostat and cardiovascular events. Methods Systematic search of randomized controlled trials was performed using PubMed/MEDLINE, Cochrane review, and EMBASE databases through April 17, 2019. M
Publikováno v:
Eur Heart J Case Rep
Background Aortopulmonary fistula is a rare complication of ascending aorta pathology. Presentation is most commonly dramatic with acute onset chest pain or heart failure secondary to left to right shunting. We describe a patient with acquired aortop
Autor:
Hadi Elias, Edwin Hernandez Campoverde, Katelyn Young, Dominik Beer, Osama Mahmoud, Maulin Patel, Steven Jacobs, Hadi Mahmaljy, Rajesh Kuppuraju, Mohamed A. Youniss, Amro Alsaid, Insia Hashmi, Matthew Stanton
Publikováno v:
Critical pathways in cardiology. 20(1)
The best management approach for chest pain patients who rule out for myocardial infarction (MI) in the high-sensitivity troponin (hsTn) era remains elusive. Patients, especially those with nonlow clinical risk scores, are often referred for inpatien
Autor:
Harini Lakshman, Di Zhao, Ibrahim Abudaya, Erin D. Michos, Mahmoud Barbarawi, Nazir Savji, Hadi Elias, Ahmad Al-Abdouh, Rani K. Hasan, Anas Bizanti, Sireesha Upadhrasta
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 21(5)
Background Percutaneous coronary intervention (PCI) is the treatment of choice for ST-elevation myocardial infarction (STEMI). However, efficacy of complete vs culprit only revascularization in patients with STEMI and multivessel disease remains uncl
Autor:
Sireesha Upadhrasta, Hadi Elias, Erin D. Michos, Di Zhao, Ahmad Al-Abdouh, Rani K. Hasan, Oluwaseun E. Fashanu
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 21(4)
INTRODUCTION Transcatheter aortic valve replacement (TAVR) has become the standard treatment option for patients with symptomatic severe aortic stenosis (AS) with high surgical risk and a reasonable option for intermediate surgical risk as an alterna
Publikováno v:
Chronic Diseases and Translational Medicine
Chronic Diseases and Translational Medicine, Vol 5, Iss 1, Pp 6-14 (2019)
Chronic Diseases and Translational Medicine, Vol 5, Iss 1, Pp 6-14 (2019)
Immuno-oncology is a fast evolving field of cancer therapy and immune checkpoint inhibitors (ICIs) are clearly a breakthrough in this field. Cardiotoxicity with conventional anti-cancer therapies has been well studied in the past and clear guidelines